RAREsummit19

Thomas Ogorka

Founder & CEO, Orphan Reach

Moderated Discussion: Disruptive innovation and transformation – Patients at the heart of the drug development process

Bio: Thomas is the founder and CEO of Orphan Reach, previously known as QED Clinical Services. Orphan Reach is a boutique contract research organization purely focused on developing new rare disease therapies for the biotech industry. Prior to establishing Orphan Reach, he held senior management and sales & marketing positions in the international CRO industry. Thomas started his pharmaceutical career as sales representative for Sanofi-Aventis and Schering.